Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Heron Therapeutics Inc (HRTX) vs Western Union Co (WU) Price & Performance

Heron Therapeutics IncTrade
Western Union CoTrade

Price performance (Past 24H)

Key statistics

Heron Therapeutics Inc vs Western Union Co — how do they compare? Heron Therapeutics Inc trades at $0.37 (market cap $68.01M), while Western Union Co trades at $6.32 (market cap $1.97B). The key difference: Western Union Co is far larger — about 29× Heron Therapeutics Inc's market cap, and Western Union Co pays a 14.85% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and Western Union Co for 95 Days on average.

HRTXWU
Market Cap
$68.01M$1.97B
Volume
1,891,94110,235,212
Sector
HealthFinancials
52-Week High
$1.49$10.28
52-Week Low
$0.27$5.90
Typical Hold Time
35 Days95 Days
Enterprise Value
$174.75M$1.88B
Dividend Yield
—14.85%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Heron Therapeutics Inc

HRTX trades at $0.39, up 17.58% today, with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7 million but missed EPS estimates with a $0.03 loss. Despite negative profitability metrics, analyst consensus remains strongly positive with 89% buy ratings. Recent news highlights ongoing comparisons with peers and earnings performance discussions.

The outlook is mixed: strong analyst support and technical momentum suggest potential upside, but persistent losses and high valuation ratios pose significant risks. Investment opportunity hinges on revenue growth translating to profitability, while key risks include execution challenges and competitive pressures in the biotechnology sector.

Western Union Co

Western Union (WU) trades at $6.11, down 0.49% on the day, with bearish technical signals and mixed earnings performance. The stock shows attractive valuation metrics with a P/E of 4.93 and P/S of 0.48, while maintaining strong profitability with 9.79% net margins. Recent developments include the pending Intermex acquisition and expansion of retail partnerships, though earnings misses in Q1 and Q2 2026 raise execution concerns. Cash flow trends show volatility with a $469M net outflow in 2025.

WU presents a value opportunity with deep valuation discounts but faces execution risks amid digital transformation. The $200M cost-cutting plan and Intermex acquisition offer potential upside if successfully implemented, while competitive pressures and integration challenges pose downside risks. Analyst consensus at $6.86 suggests modest upside from current levels, though the mixed rating distribution reflects uncertainty about the turnaround strategy.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HRTX
8% Buy92% Sell
Avg holding period · 35 Days
WU

No sentiment data available yet.

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Read more on HRTX →

About Western Union Co

Western Union provides domestic and international money transfers through its global network of about 500,000 outside agents. It is the largest money transfer company in the world and one of only a few companies with a truly global agent network.

Read more on WU →